Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Avexitide, which has been granted FDA breakthrough therapy designation, has shown significant effectiveness in treating Postbariatric Hypoglycemia (PBH) and congenital hyperinsulinism, and is expected to commence Phase 3 trials for PBH by early 2025
Unsurprisingly, demand has surged across the U.S., with employers now facing mounting pressure to cover them
These prescription drugs prices can also be affected by the type of insurance one has
Further trials will look at use in people with diabetes, adolescents and other high-risk groups
Monitor Your Timing: If you must take an oral antihistamine, try to take it at a time of day when your stomach is less likely to be full, or space it out from your weekly injection if you find your digestive system is most sluggish in the 24 hours following your dose
